Related Experiment Video
Updated: May 19, 2026

Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney
Ashok Kumar Yadav1, Anupam Lal, Vivekanand Jha
1Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Chronic kidney disease (CKD) patients show increased CD4(+)CD28(null) T cells, which are cytotoxic and linked to early atherosclerosis. Tumor necrosis factor-alpha (TNF-α) may drive this expansion in CKD.
Area of Science:
- Immunology
- Nephrology
- Cardiovascular Disease
Background:
- CD4(+) T cells lacking CD28 (CD4(+)CD28(null)) are implicated in atherosclerosis.
- The role of CD4(+)CD28(null) T cells in early atherosclerotic changes in chronic kidney disease (CKD) remains uninvestigated.
Purpose of the Study:
- To evaluate the frequency of circulating CD4(+)CD28(null) T cells in CKD patients.
- To assess the association between CD4(+)CD28(null) T cells and preclinical atherosclerotic changes in CKD.
Main Methods:
- Flow cytometry was used to determine CD4(+)CD28(null) cell phenotype and cytotoxic potential (perforin, granzyme B).
- Systemic inflammation markers (hsCRP, IL-6, TNF-α) were measured by ELISA.
- Carotid intima-media thickness (CCA-IMT) was assessed via ultrasound; in vitro experiments explored cytokine effects.
Main Results:
- CKD patients exhibited significantly higher frequencies of CD4(+)CD28(null) cells compared to controls.
- These cells showed increased cytotoxic markers and correlated positively with CCA-IMT.
- Elevated TNF-α levels in CKD correlated with CD4(+)CD28(null) cells, and TNF-α induced CD28 downregulation in vitro.
Conclusions:
- CKD is associated with an expanded population of circulating cytotoxic CD4(+)CD28(null) T lymphocytes.
- The expansion of CD4(+)CD28(null) cells correlates with preclinical atherosclerotic changes in CKD.
- TNF-α appears to play a specific role in the expansion of this T cell subset in CKD patients.
Background/Aims:
The CD4(+) T cell subset lacking surface CD28 plays a role in atherosclerotic cardiovascular disease. The association between CD4(+)CD28(null) T cells and early atherosclerotic changes in chronic kidney disease (CKD) has never been investigated. We evaluated the frequency of circulating CD4(+)CD28(null) cells in 128 CKD and 62 control subjects.
Methods:
Phenotype (CD4 and CD28) and cytotoxic potential (perforin and granzyme B expression) were studied by flow cytometry. Systemic inflammation (hsCRP, IL-6 and TNF-α) was analyzed by ELISA. Common carotid artery intima-media thickness (CCA-IMT) was measured with an ultrasound system. The effect of TNF-α and IL-6 on these cells was evaluated in vitro.
Results:
The frequency of CD4(+)CD28(null) cells was significantly increased in CKD patients (10.14 ± 0.8 vs. 3.53 ± 0.36, p < 0.0001). The expression of perforin and granzyme B on CD4(+)CD28(null) cells was found to be significantly higher compared to CD4(+)CD28(+) cells (p < 0.0001). A larger proportion of CD4(+)CD28(null) cells obtained from CKD subjects showed the expression of perforin and granzyme B compared to those from healthy controls. CKD patients showed increased CCA-IMT (p < 0.0001). CD4(+)CD28(null) cells were positively correlated with the IMT (r = 0.505, p < 0.0001). CKD subjects showed increased levels of hsCRP, IL-6 and TNF-α. Only the TNF-α level showed a correlation with CD4(+)CD28(null) cells (r = 0.45, p < 0.0001). In vitro treatment with TNF-α but not IL-6 resulted in further downregulation of CD28 on the CD4(+) T cell surface.
Conclusions:
CKD subjects exhibit an increase in the circulating cytotoxic CD4(+)CD28(null) T lymphocyte population. CD4(+)CD28(null) cell expansion correlated with preclinical atherosclerotic changes. TNF-α shows a specific relationship and might have a role in the expansion of this subset in CKD.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care

